NDRA ENDRA Life Sciences Inc

Price (delayed)

$0.0794

Market cap

$876,231

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.14

Enterprise value

$65,594

ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), a ground-breaking technology being developed to visualize tissue like MRI, but at 1/50th the cost and at the ...

Highlights
The company's EPS has surged by 73% YoY and by 28% QoQ
The debt has decreased by 36% YoY and by 18% from the previous quarter
The company's quick ratio has shrunk by 70% QoQ and by 28% YoY
NDRA's equity is down by 35% since the previous quarter and by 18% year-on-year

Key stats

What are the main financial stats of NDRA
Market
Shares outstanding
11.04M
Market cap
$876,231
Enterprise value
$65,594
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.24
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$9.89M
EBITDA
-$9.63M
Free cash flow
-$9.21M
Per share
EPS
-$1.14
Free cash flow per share
-$0.85
Book value per share
$0.34
Revenue per share
$0
TBVPS
$0.47
Balance sheet
Total assets
$5.06M
Total liabilities
$1.36M
Debt
$324,064
Equity
$3.7M
Working capital
$53,818
Liquidity
Debt to equity
0.09
Current ratio
1.04
Quick ratio
0.93
Net debt/EBITDA
0.08
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-138.1%
Return on equity
-184.2%
Return on invested capital
-334.1%
Return on capital employed
-257.4%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NDRA stock price

How has the ENDRA Life Sciences stock price performed over time
Intraday
-0.75%
1 week
-13.7%
1 month
-33.83%
1 year
-94.12%
YTD
-96.25%
QTD
-18.14%

Financial performance

How have ENDRA Life Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$10.37M
Net income
-$9.89M
Gross margin
N/A
Net margin
N/A
ENDRA Life Sciences's net income has increased by 25% YoY
The operating income rose by 22% year-on-year

Growth

What is ENDRA Life Sciences's growth rate over time

Valuation

What is ENDRA Life Sciences stock price valuation
P/E
N/A
P/B
0.24
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS has surged by 73% YoY and by 28% QoQ
NDRA's P/B is 94% less than its 5-year quarterly average of 3.7 and 88% less than its last 4 quarters average of 2.0
NDRA's equity is down by 35% since the previous quarter and by 18% year-on-year

Efficiency

How efficient is ENDRA Life Sciences business performance
The return on equity has declined by 22% year-on-year
The company's return on invested capital rose by 21% YoY and by 2.1% QoQ
The ROA has declined by 13% year-on-year and by 3.8% since the previous quarter

Dividends

What is NDRA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NDRA.

Financial health

How did ENDRA Life Sciences financials performed over time
The company's quick ratio has shrunk by 70% QoQ and by 28% YoY
ENDRA Life Sciences's current ratio has shrunk by 69% QoQ and by 65% YoY
The debt is 91% less than the equity
The debt has decreased by 36% YoY and by 18% from the previous quarter
NDRA's equity is down by 35% since the previous quarter and by 18% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.